D

DURECT Corp
D

DRRX

0.57990
USD
0.01
(1.74%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
18,001,593
أصول ذات صلة
A
ALDX
-0.27500
(-5.06%)
5.16000 USD
A
AQST
-0.05500
(-1.31%)
4.15000 USD
A
AXSM
-4.200
(-4.00%)
100.830 USD
B
BHC
0.00000
(0.00%)
6.78000 USD
B
BNTC
-0.850
(-7.07%)
11.170 USD
CAH
CAH
-1.020
(-0.64%)
157.160 USD
المزيد
الأخبار المقالات

العنوان: DURECT Corp

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entitiesand proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.